vs
Cambium Networks Corp（CMBM）与RECURSION PHARMACEUTICALS, INC.（RXRX）财务数据对比。点击上方公司名可切换其他公司
Cambium Networks Corp的季度营收约是RECURSION PHARMACEUTICALS, INC.的1.1倍（$40.3M vs $35.5M），Cambium Networks Corp净利率更高（-17.9% vs -304.2%，领先286.3%），RECURSION PHARMACEUTICALS, INC.同比增速更快（681.7% vs -23.2%），Cambium Networks Corp自由现金流更多（$-10.8M vs $-47.3M），过去两年RECURSION PHARMACEUTICALS, INC.的营收复合增速更高（60.5% vs -27.2%）
坎布里姆网络公司是美国的无线通信设备制造商，主营企业WiFi、网络交换设备、物联网相关产品，以及面向企业的固定无线宽带、WiFi接入产品。该公司于2011年10月从摩托罗拉分拆，目前在纳斯达克上市。
Recursion Pharmaceuticals是一家临床阶段生物技术企业，依托人工智能技术和高通量生物实验体系，开发针对罕见病、肿瘤、炎症性疾病等领域未满足医疗需求的创新疗法，核心市场覆盖北美，与全球多家生物制药企业合作推进在研管线落地。
CMBM vs RXRX — 直观对比
损益表 — Q4 FY2024 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $40.3M | $35.5M |
| 净利润 | $-7.2M | $-108.1M |
| 毛利率 | 36.6% | 59.8% |
| 营业利润率 | -28.4% | -304.8% |
| 净利率 | -17.9% | -304.2% |
| 营收同比 | -23.2% | 681.7% |
| 净利润同比 | 71.0% | 39.6% |
| 每股收益（稀释后） | $-0.26 | $-0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | — | $35.5M | ||
| Q3 25 | — | $5.2M | ||
| Q2 25 | — | $19.2M | ||
| Q1 25 | — | $14.7M | ||
| Q4 24 | $40.3M | $4.5M | ||
| Q3 24 | $44.7M | $26.1M | ||
| Q2 24 | $45.2M | $14.4M | ||
| Q1 24 | $47.1M | $13.8M |
| Q4 25 | — | $-108.1M | ||
| Q3 25 | — | $-162.3M | ||
| Q2 25 | — | $-171.9M | ||
| Q1 25 | — | $-202.5M | ||
| Q4 24 | $-7.2M | $-178.9M | ||
| Q3 24 | $-34.5M | $-95.8M | ||
| Q2 24 | $-14.2M | $-97.5M | ||
| Q1 24 | $-18.4M | $-91.4M |
| Q4 25 | — | 59.8% | ||
| Q3 25 | — | -183.8% | ||
| Q2 25 | — | -4.9% | ||
| Q1 25 | — | -48.0% | ||
| Q4 24 | 36.6% | -181.4% | ||
| Q3 24 | 43.6% | 53.7% | ||
| Q2 24 | 32.5% | 36.2% | ||
| Q1 24 | 29.8% | 19.1% |
| Q4 25 | — | -304.8% | ||
| Q3 25 | — | -3327.6% | ||
| Q2 25 | — | -916.8% | ||
| Q1 25 | — | -1297.9% | ||
| Q4 24 | -28.4% | -4042.4% | ||
| Q3 24 | -69.6% | -377.1% | ||
| Q2 24 | -27.2% | -697.4% | ||
| Q1 24 | -33.1% | -698.4% |
| Q4 25 | — | -304.2% | ||
| Q3 25 | — | -3135.3% | ||
| Q2 25 | — | -894.2% | ||
| Q1 25 | — | -1373.3% | ||
| Q4 24 | -17.9% | -3935.5% | ||
| Q3 24 | -77.3% | -367.5% | ||
| Q2 24 | -31.5% | -676.6% | ||
| Q1 24 | -39.2% | -662.4% |
| Q4 25 | — | $-0.17 | ||
| Q3 25 | — | $-0.36 | ||
| Q2 25 | — | $-0.41 | ||
| Q1 25 | — | $-0.50 | ||
| Q4 24 | $-0.26 | $-0.56 | ||
| Q3 24 | $-1.22 | $-0.34 | ||
| Q2 24 | $-0.51 | $-0.40 | ||
| Q1 24 | $-0.66 | $-0.39 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $743.3M |
| 总债务越低越好 | $67.6M | $9.6M |
| 股东权益账面价值 | $-3.2M | $1.1B |
| 总资产 | $173.7M | $1.5B |
| 负债/权益比越低杠杆越低 | — | 0.01× |
8季度趋势，按日历期对齐
| Q4 25 | — | $743.3M | ||
| Q3 25 | — | $659.8M | ||
| Q2 25 | — | $525.1M | ||
| Q1 25 | — | $500.5M | ||
| Q4 24 | — | $594.4M | ||
| Q3 24 | — | $427.6M | ||
| Q2 24 | — | $474.3M | ||
| Q1 24 | — | $296.3M |
| Q4 25 | — | $9.6M | ||
| Q3 25 | — | $11.9M | ||
| Q2 25 | — | $14.2M | ||
| Q1 25 | — | $16.4M | ||
| Q4 24 | $67.6M | $19.0M | ||
| Q3 24 | $67.6M | $20.5M | ||
| Q2 24 | $68.9M | $22.9M | ||
| Q1 24 | $63.8M | — |
| Q4 25 | — | $1.1B | ||
| Q3 25 | — | $1.0B | ||
| Q2 25 | — | $919.1M | ||
| Q1 25 | — | $933.9M | ||
| Q4 24 | $-3.2M | $1.0B | ||
| Q3 24 | $1.9M | $524.6M | ||
| Q2 24 | $34.1M | $584.4M | ||
| Q1 24 | $45.0M | $401.2M |
| Q4 25 | — | $1.5B | ||
| Q3 25 | — | $1.4B | ||
| Q2 25 | — | $1.3B | ||
| Q1 25 | — | $1.3B | ||
| Q4 24 | $173.7M | $1.4B | ||
| Q3 24 | $194.3M | $726.5M | ||
| Q2 24 | $221.1M | $775.9M | ||
| Q1 24 | $219.8M | $557.8M |
| Q4 25 | — | 0.01× | ||
| Q3 25 | — | 0.01× | ||
| Q2 25 | — | 0.02× | ||
| Q1 25 | — | 0.02× | ||
| Q4 24 | — | 0.02× | ||
| Q3 24 | 36.12× | 0.04× | ||
| Q2 24 | 2.02× | 0.04× | ||
| Q1 24 | 1.42× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-10.4M | $-46.1M |
| 自由现金流经营现金流 - 资本支出 | $-10.8M | $-47.3M |
| 自由现金流率自由现金流/营收 | -26.8% | -133.1% |
| 资本支出强度资本支出/营收 | 1.1% | 3.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-21.4M | $-378.3M |
8季度趋势，按日历期对齐
| Q4 25 | — | $-46.1M | ||
| Q3 25 | — | $-117.4M | ||
| Q2 25 | — | $-76.4M | ||
| Q1 25 | — | $-132.0M | ||
| Q4 24 | $-10.4M | $-115.4M | ||
| Q3 24 | $8.9M | $-59.2M | ||
| Q2 24 | $2.4M | $-82.2M | ||
| Q1 24 | $-15.9M | $-102.3M |
| Q4 25 | — | $-47.3M | ||
| Q3 25 | — | $-117.6M | ||
| Q2 25 | — | $-79.6M | ||
| Q1 25 | — | $-133.8M | ||
| Q4 24 | $-10.8M | $-116.7M | ||
| Q3 24 | $6.8M | $-63.8M | ||
| Q2 24 | $87.0K | $-83.4M | ||
| Q1 24 | $-17.4M | $-109.0M |
| Q4 25 | — | -133.1% | ||
| Q3 25 | — | -2272.5% | ||
| Q2 25 | — | -413.9% | ||
| Q1 25 | — | -907.4% | ||
| Q4 24 | -26.8% | -2567.7% | ||
| Q3 24 | 15.2% | -244.6% | ||
| Q2 24 | 0.2% | -578.5% | ||
| Q1 24 | -37.0% | -789.9% |
| Q4 25 | — | 3.5% | ||
| Q3 25 | — | 4.7% | ||
| Q2 25 | — | 16.4% | ||
| Q1 25 | — | 12.4% | ||
| Q4 24 | 1.1% | 28.6% | ||
| Q3 24 | 4.8% | 17.5% | ||
| Q2 24 | 5.1% | 8.2% | ||
| Q1 24 | 3.3% | 48.2% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CMBM
| Enterprise | $16.6M | 41% |
| Point To Multi Point | $16.4M | 41% |
| Other | $5.8M | 14% |
RXRX
暂无分部数据
